首页> 美国卫生研究院文献>GMS German Medical Science >Parenteral nutrition in patients with renal failure – Guidelines on Parenteral Nutrition Chapter 17
【2h】

Parenteral nutrition in patients with renal failure – Guidelines on Parenteral Nutrition Chapter 17

机译:肾衰竭患者的肠胃外营养-肠外营养指南第17章

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Partial EN (enteral nutrition) should always be aimed for in patients with renal failure that require nutritional support. Nevertheless PN (parenteral nutrition) may be necessary in renal failure in patient groups with acute or chronic renal failure (ARF or CRF) and additional acute diseases but without extracorporeal renal replacement therapy, or in patients with ARF or CRF with additional acute diseases on extracorporeal renal replacement therapy, haemodialysis therapy (HD), peritoneal dialysis (PD) or continuous renal replacement therapy (CRRT), or in patients on HD therapy with intradialytic PN. Patients with renal failure who show marked metabolic derangements and changes in nutritional requirements require the use of specifically adapted nutrient solutions. The substrate requirements of acutely ill, non-hypercatabolic patients with CRF correspond to those of patients with ARF who are not receiving any renal replacement patients therapy (utilisation of the administered nutrients has to be monitored carefully). In ARF patients and acutely ill CRF patients on renal replacement therapy, substrate requirements depend on disease severity, type and extent/frequency of extracorporeal renal replacement therapy, nutritional status, underlying disease and complications occurring during the course of the disease. Patients under HD have a higher risk of developing malnutrition. Intradialytic PN (IDPN) should be used if causes of malnutrition cannot be eliminated and other interventions fail. IDPN should only be carried out when modifiable causes of malnutrition are excluded and enhanced oral (like i.e. additional energy drinks) or enteral supply is unsuccessful or cannot be carried out.
机译:EN部分营养(肠内营养)应始终针对需要营养支持的肾衰竭患者。但是,对于患有急性或慢性肾功能衰竭(ARF或CRF)并伴有其他急性疾病但没有体外肾替代疗法的患者组,肾衰竭可能仍需要PN(肠外营养),或者对于具有体外急性肾病的ARF或CRF的患者肾脏替代疗法,血液透析疗法(HD),腹膜透析(PD)或连续性肾脏替代疗法(CRRT),或接受透析内PN的HD治疗的患者。表现出明显的代谢紊乱和营养需求变化的肾衰竭患者需要使用经过特殊调整的营养液。急性病,非高分解代谢性CRF患者的底物需求量与未接受任何肾脏替代患者治疗的ARF患者的底物需求量有关(必须仔细监测营养素的利用)。在接受肾替代疗法的ARF患者和重症CRF患者中,底物需求取决于疾病的严重程度,体外肾替代疗法的类型和程度/频率,营养状况,潜在疾病以及在疾病过程中发生的并发症。 HD下的患者发生营养不良的风险更高。如果营养不良的原因无法消除并且其他干预措施失败,则应使用透析内PN(IDPN)。仅在排除营养不良的可改变原因并且口服增强剂(例如补充能量饮料)或肠内供应不成功或无法进行时,才应进行IDPN。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号